Lisa Friedman L C S W Inc - Medicare Mental Health Clinic in Plantation, FL

Lisa Friedman L C S W Inc is a medicare enrolled mental health clinic (Social Worker - Clinical) in Plantation, Florida. The current practice location for Lisa Friedman L C S W Inc is 7376 Nw 5th St, Plantation, Florida. For appointments, you can reach them via phone at (954) 741-1099. The mailing address for Lisa Friedman L C S W Inc is 9715 W Broward Blvd, P. M. Box 148, Plantation, Florida and phone number is (954) 741-1099.

Lisa Friedman L C S W Inc is licensed to practice in Florida (license number SW5369). The clinic also participates in the medicare program and its NPI number is 1124379821. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (954) 741-1099.

Contact Information

Lisa Friedman L C S W Inc
7376 Nw 5th St
Plantation
FL 33317-1605
(954) 741-1099
(954) 585-0177

Mental Health Clinic Profile

Full NameLisa Friedman L C S W Inc
SpecialitySocial Worker
Location7376 Nw 5th St, Plantation, Florida
Authorized Official Name and PositionLisa Friedman (PRESIDENT)
Authorized Official Contact9547411099
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lisa Friedman L C S W Inc
9715 W Broward Blvd
P. M. Box 148
Plantation
FL 33324-2351

Ph: (954) 741-1099
Lisa Friedman L C S W Inc
7376 Nw 5th St
Plantation
FL 33317-1605

Ph: (954) 741-1099

NPI Details:

NPI Number1124379821
Provider Enumeration Date09/21/2012
Last Update Date09/21/2012

Medicare PECOS Information:

Medicare PECOS PAC ID9436308509
Medicare Enrollment IDO20121004000512

News Archive

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

New computer models successfully link donors and kidney transplant patients

New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.

Meningitis B vaccine's high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.

Read more Medical News

› Verified 8 days ago

Medical Identifiers

Medical identifiers for Lisa Friedman L C S W Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1124379821NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical SW5369 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Lisa Friedman L C S W Inc acts as a billing entity for following providers:
Provider NameLisa B Friedman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1497834154
PECOS PAC ID: 6204859937
Enrollment ID: I20060109000994

News Archive

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

New computer models successfully link donors and kidney transplant patients

New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.

Meningitis B vaccine's high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.

Read more Medical News

› Verified 8 days ago

Provider NameSusan Shafran
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1699788596
PECOS PAC ID: 2264618826
Enrollment ID: I20121206000130

News Archive

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

New computer models successfully link donors and kidney transplant patients

New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.

Meningitis B vaccine's high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.

Read more Medical News

› Verified 8 days ago

Provider NameShantreirra Monroe
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1194169474
PECOS PAC ID: 1951659168
Enrollment ID: I20180803002365

News Archive

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

New computer models successfully link donors and kidney transplant patients

New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.

Meningitis B vaccine's high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.

Read more Medical News

› Verified 8 days ago

Provider NameMichelle Friedland
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831809995
PECOS PAC ID: 1850765322
Enrollment ID: I20230323002434

News Archive

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

New computer models successfully link donors and kidney transplant patients

New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.

Meningitis B vaccine's high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.

Read more Medical News

› Verified 8 days ago

News Archive

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

New computer models successfully link donors and kidney transplant patients

New computer models can now link strangers in a life-saving chain of kidney transplants, promising to increase the number of transplants and overcome obstacles posed by logistics or donors who renege, a team of researchers report in the current edition of the New England Journal of Medicine.

Meningitis B vaccine's high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.

GOP officials press for health law delay, Sebelius to resign; Democrats urge patience

The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.

Read more News

› Verified 8 days ago

Social Worker in Plantation, FL

Iatac
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 4101 S Hospital Dr, Plantation, FL 33317
Phone: 954-999-0818    Fax: 954-999-0947
Ruskin-mccormick Mds Pa
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 350 Nw 84th Ave, Suite 109, Plantation, FL 33324
Phone: 954-424-9444    
Dr. Helen R. Ackerman, P.a.
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 5921 Almond Ter, Plantation, FL 33317
Phone: 954-791-6373    Fax: 954-581-8516
Neurology Associates Of South Florida Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 201 Nw 82nd Ave, Suite 502, Plantation, FL 33324
Phone: 954-236-6602    Fax: 954-236-8045
Aprendo Autism Center Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 261 N University Dr Ste 500-90, Plantation, FL 33324
Phone: 954-662-3978    
Adept Behavioral Management
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7540 Nw 9th St, Plantation, FL 33317
Phone: 305-546-8974    Fax: 855-565-3603
Americas Behavioral Institute Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7341 Nw 10th Ct, Plantation, FL 33313
Phone: 954-740-0580    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.